A federal appeals court on Monday postponed the effect of a trial judge's injunction that would have barred Medtronic Inc. from selling its new CoreValve heart device in the U.S.. The U.S. Court of Appeals for the Federal Circuit, in a short 2-1 decision, issued an order that delays the injunction until further notice. It was to go into effect at the close of business Tuesday. . A...
  